Correlation Between Effector Therapeutics and AbbVie

Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Effector Therapeutics and AbbVie Inc, you can compare the effects of market volatilities on Effector Therapeutics and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and AbbVie.

Diversification Opportunities for Effector Therapeutics and AbbVie

0.85

Correlation Coefficient

Effector Therapeutics  AbbVie

Very poor diversification

The 3 months correlation between Effector and AbbVie is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and AbbVie go up and down completely randomly.

Pair Corralation between Effector Therapeutics and AbbVie

Given the investment horizon of 90 days Effector Therapeutics is expected to generate 4.06 times more return on investment than AbbVie. However, Effector Therapeutics is 4.06 times more volatile than AbbVie Inc. It trades about 0.05 of its potential returns per unit of risk. AbbVie Inc is currently generating about -0.08 per unit of risk. If you would invest  213.00  in Effector Therapeutics on February 7, 2024 and sell it today you would earn a total of  7.00  from holding Effector Therapeutics or generate 3.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	95.45%
Values	Daily Returns

Effector Therapeutics  vs.  AbbVie Inc

Effector Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Effector Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with fragile performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in June 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

AbbVie Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AbbVie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental drivers, AbbVie is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Effector Therapeutics and AbbVie

The main advantage of trading using opposite Effector Therapeutics and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.

The idea behind Effector Therapeutics and AbbVie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.